World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
26304
World Ranking
1668
National Ranking
59

Overview

Stephen J. Kent is affiliated with the University of Melbourne in Australia. Their research primarily focuses on medicine with a particular emphasis on immunology and microbiology.

The main fields of study covered by their publications include:

  • Medicine
  • Immunology and Microbiology

Their work also spans several subfields such as:

  • Infectious Diseases
  • Immunology
  • Epidemiology
  • Molecular Biology
  • Radiology, Nuclear Medicine and Imaging

Key topics investigated in their research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Immunotherapy and Immune Responses
  • Influenza Virus Research Studies
  • T-cell and B-cell Immunology
  • Monoclonal and Polyclonal Antibodies Research

Frequent publication venues for this scientist consist of:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical & Translational Immunology
  • Frontiers in Immunology
  • Nature Communications
  • Immunology and Cell Biology

Stephen J. Kent has collaborated extensively with coauthors including:

  • Adam K. Wheatley
  • Jennifer A. Juno
  • Hyon-Xhi Tan
  • Amy W. Chung
  • Katherine Kedzierska

Recent papers from this scientist include:

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, 2021, Nature Medicine
  • Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, 2022, Nature Immunology
  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies, 2020, Nature Microbiology
  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19, 2020, Nature Medicine
  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19, 2021, Nature Communications

Best Publications

  • Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.

    David S. Khoury;Deborah Cromer;Arnold Reynaldi;Timothy E. Schlub;Timothy E. Schlub

  • Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation

    Laura K. Mackay;Angus T. Stock;Joel Z. Ma;Claerwen M. Jones

  • Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

    Wen Shi Lee;Adam K Wheatley;Stephen J Kent;Stephen J Kent;Brandon J DeKosky

  • Minimum information reporting in bio-nano experimental literature.

    Matthew Faria;Mattias Björnmalm;Kristofer J. Thurecht;Stephen J. Kent

  • Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus

    Stephen J. Kent;Anne Zhao;Susan J. Best;Jenalle D. Chandler

  • Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19.

    Jennifer A. Juno;Hyon Xhi Tan;Wen Shi Lee;Arnold Reynaldi

  • Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.

    Marc Rigau;Marc Rigau;Simone Ostrouska;Thomas S Fulford;Darryl N Johnson

  • Tuberculous Meningitis: A 30-Year Review

    Kent Sj;Crowe Sm;Yung A;Lucas Cr

  • Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.

    Adam K Wheatley;Jennifer A Juno;Jing J Wang;Kevin J Selva

  • Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.

    Deborah Cromer;Megan Steain;Arnold Reynaldi;Timothy E Schlub;Timothy E Schlub

  • Photometric Redshifts for the SDSS Early Data Release

    Istvan Csabai;Tamas Budavari;Andrew J. Connolly;Alexander S. Szalay

  • Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

    Deborah Cromer;Jennifer A. Juno;David Khoury;Arnold Reynaldi

  • A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface

    Sandhya Bangaru;Shanshan Lang;Michael Schotsaert;Hillary A. Vanderven

  • Cross-Reactive Influenza-Specific Antibody-Dependent Cellular Cytotoxicity Antibodies in the Absence of Neutralizing Antibodies

    Sinthujan Jegaskanda;Emma R. Job;Marit Kramski;Karen Laurie

  • From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.

    Emily H. Pilkington;Estelle J.A. Suys;Natalie L. Trevaskis;Adam K. Wheatley

  • Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

    Marios Koutsakos;Adam K. Wheatley;Liyen Loh;E. Bridie Clemens

  • Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery

    Katelyn T. Gause;Adam K. Wheatley;Jiwei Cui;Yan Yan

  • Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.

    Henry J. Sutton;Racheal Aye;Racheal Aye;Azza H. Idris;Rachel Vistein

  • Antibody-Dependent Cellular Cytotoxicity Is Associated with Control of Pandemic H1N1 Influenza Virus Infection of Macaques

    Sinthujan Jegaskanda;Jason T. Weinfurter;Thomas C. Friedrich;Stephen J. Kent

  • Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost

    Caroline S Fernandez;Ivan Stratov;Robert De Rose;Katrina Walsh

  • Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors

    Oliver Hartley;Hubert François Gaertner;Jill Wilken;Darren Thompson

  • Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection

    Chansavath Phetsouphanh;David Darley;Anette Howe;C. Mee Ling Munier

Frequent Co-Authors

Adam K. Wheatley
Adam K. Wheatley University of Melbourne
Miles P. Davenport
Miles P. Davenport University of New South Wales
Anthony D. Kelleher
Anthony D. Kelleher University of New South Wales
P. Mark Hogarth
P. Mark Hogarth Burnet Institute
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Damian F. J. Purcell
Damian F. J. Purcell University of Melbourne
Ian A. Ramshaw
Ian A. Ramshaw University of Canberra
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
David A. Cooper
David A. Cooper University of New South Wales
Thomas P. Davis
Thomas P. Davis University of Queensland

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse careers in healthcare, research, and biotechnology. For those interested in nursing pathways, there are several accelerated and flexible online options to consider. For instance, exploring an accelerated FNP program can fast-track your education toward becoming a Family Nurse Practitioner.

If you are an existing nurse looking to specialize further, understanding how to transition from FNP to ACNP can be a valuable step in advancing your clinical expertise and career opportunities. This transition often requires additional certifications but can significantly enhance your ability to work in acute care settings with complex patients.

For those coming from non-nursing backgrounds, several online nursing programs for non nurses offer pathways into the nursing profession without traditional prerequisites. These programs provide foundational knowledge and clinical training to start your journey in healthcare.

Additionally, if you’re looking for an entry point, the easiest ABSN programs to get into provide accessible options to earn a Bachelor of Science in Nursing quickly, helping you begin your nursing career sooner while complementing your immunology background.

Best Scientists Citing Stephen J. Kent

Trending Scientists

Recently Published Articles